Growing Popularity of Inhalers is Propelling the Growth of the Global Nasal Drug Delivery Mode market

 The rising number of asthma and rhinitis patients globally, increasing air pollution along with rising consumption of tobacco smoke and escalating approval of the government bodies on nasal drug are some of the factor driving the growth of Global nasal drug delivery mode market. Besides these, growing popularity of inhalers, snowballing research and development by the market players and burgeoning practices of self-administration are placing a significant impact on the growth of the nasal drug delivery market. Moreover, the outbreak COVID-19 has a positive impact on the market as the virus has surged the concern of people with asthma or rhinitis as these are likely to get SARS-CoV-2 as the virus attacks the lungs and can trigger asthma symptoms like wheezing, chest tightness and difficulty breathing. Thus, to overcome this issue the demand for nasal drug is proliferating which is expected to accelerate the market growth of nasal drug delivery mode.

Based on Dosage Form, Spray segment grabbed the majority market share in 2019. The growth of the segment is attributed to considerable rise in the number of patients suffering from chronic rhinitis, the introduction of new products in the nasal spray for easy administration, and surging adoption of self-administration practice are expected to fuel the demand for nasal sprays in the coming years.

Asia-Pacific is expected to attain highest CAGR by 2025. This is due to rising consumption of tobacco in the countries such as China, India, increasing air pollution and escalating investment in research & development activities. Moreover, growing prevalence of chronic diseases in peoples such as asthma and rising self-administration amongst individual and burgeoning awareness about the eco-friendly inhaler are strongly contributing to the growth of the market.

The key players with a considerable market share in the Global Nasal Drug Delivery Mode market are Merck & Co., Inc., GlaxoSmithKline Plc, AstraZeneca, Johnson & Johnson Services Inc., Mystic Pharmaceuticals, Bausch Health, BD, 3M, AptarGroup, Inc., OptiNose US, Inc., Dr. Reddy’s Laboratories Ltd., Flo Nasal Products, Cadila Pharmaceuticals, PendoPharm Inc, Neurelis, Inc.